These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1744074)

  • 21. The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity.
    Pham T; Kodvawala A; Hui DY
    Biochemistry; 2005 May; 44(20):7577-82. PubMed ID: 15896001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural characterization of a low density lipoprotein receptor-active apolipoprotein E peptide, ApoE3-(126-183).
    Raussens V; Mah MK; Kay CM; Sykes BD; Ryan RO
    J Biol Chem; 2000 Dec; 275(49):38329-36. PubMed ID: 10986285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS; Fazio S; Mahley RW
    J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
    Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE
    J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-VLDL and acetylated-LDL binding to pigeon monocyte macrophages.
    Henson DA; St Clair RW; Lewis JC
    Atherosclerosis; 1989 Jul; 78(1):47-60. PubMed ID: 2667527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of apoE content on receptor binding of large, bouyant LDL in subjects with different LDL subclass phenotypes.
    Barbagallo CM; Levine GA; Blanche PJ; Ishida BY; Krauss RM
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):466-72. PubMed ID: 9514416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro.
    Sugiyama T; Kumagai H; Morikawa Y; Wada Y; Sugiyama A; Yasuda K; Yokoi N; Tamura S; Kojima T; Nosaka T; Senba E; Kimura S; Kadowaki T; Kodama T; Kitamura T
    Biochemistry; 2000 Dec; 39(51):15817-25. PubMed ID: 11123907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro.
    Medh JD; Bowen SL; Fry GL; Ruben S; Andracki M; Inoue I; Lalouel JM; Strickland DK; Chappell DA
    J Biol Chem; 1996 Jul; 271(29):17073-80. PubMed ID: 8663292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: a saturable pathway distinct from the LDL receptor.
    Wang-Iverson P; Ginsberg HN; Peteanu LA; Le NA; Brown WV
    Biochem Biophys Res Commun; 1985 Jan; 126(1):578-86. PubMed ID: 3970709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors.
    Medh JD; Fry GL; Bowen SL; Pladet MW; Strickland DK; Chappell DA
    J Biol Chem; 1995 Jan; 270(2):536-40. PubMed ID: 7822276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor.
    Olsson U; Camejo G; Hurt-Camejo E; Elfsber K; Wiklund O; Bondjers G
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):149-55. PubMed ID: 9012650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
    J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E mimetics and cholesterol-lowering properties.
    Sharifov OF; Nayyar G; Garber DW; Handattu SP; Mishra VK; Goldberg D; Anantharamaiah GM; Gupta H
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):371-81. PubMed ID: 22149316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for isomerization during binding of apolipoprotein-B100 to low density lipoprotein receptors.
    Chappell DA; Fry GL; Waknitz MA; Berns JJ
    J Biol Chem; 1992 Jan; 267(1):270-9. PubMed ID: 1730595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
    J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of Lipid Nanodisks Containing Apolipoprotein E-Derived Synthetic Peptides for Biocompatible Delivery Vehicles Targeting Low-Density Lipoprotein Receptor.
    Tanaka M; Hasegawa M; Yoshimoto N; Hoshikawa K; Mukai T
    Biol Pharm Bull; 2019; 42(8):1376-1383. PubMed ID: 31366872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low apparent affinity for low-density lipoprotein of receptors expressed by human macrophages maintained with whole serum.
    Knight BL; Soutar AK
    Eur J Biochem; 1986 Apr; 156(1):205-10. PubMed ID: 3956506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia.
    Bihain BE; Yen FT
    Biochemistry; 1992 May; 31(19):4628-36. PubMed ID: 1581314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits.
    Wernette-Hammond ME; Garcia Z; Arnold KS; Innerarity TL
    Arteriosclerosis; 1989; 9(4):501-10. PubMed ID: 2546526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.